Skip to content

The effect of gensing on sexual function in postmenopausal women with major depression

The effect of gensing on sexual function in postmenopausal women with major depression: a randomized controlled clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120718010324N74
Enrollment
66
Registered
2022-12-10
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression. Depressive episode

Interventions

Intervention 1: Intervention group: The participants (33 people) will receive ginseng capsule with a dose of 250 mg. The time to take the supplement will be twice a day and after meals. The duration o

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Postmenopausal women with major depressive disorder confirmed by the psychiatrist colleague of the research team Age 40-65 years Having a steady sexual partner Having sexual intercourse at least once a month At least 12 months have passed since their last period. FSFI score less than 28 No change in treatment plan during the past and future 2 months (including no current treatment, stable use of antidepressants, or continuous non-pharmacological treatment) Having reading and writing literacy

Exclusion criteria

Exclusion criteria: Having chronic diseases, including cardiovascular, liver, diabetes, kidney and endocrine diseases, according to medical records Hormone therapy for any reason during the last 2 months Blood pressure above 140/90 based on measurement by the researcher and medical records Continuous use of other herbal medicines Taking medications that interfere with ginseng, such as diabetes medications, immunosuppressants, and warfarin Having a history of allergy to herbal medicines

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: Before and after the end of intervention. Method of measurement: Female Sexual Function Index.

Secondary

MeasureTime frame
Menopausal symptoms. Timepoint: Before and after the end of intervention. Method of measurement: Green scale.;Depression. Timepoint: Before and after the end of intervention. Method of measurement: Beck depression questionnaire.;Side events. Timepoint: During the intervention. Method of measurement: Side events checklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Sharifpoor

Tabriz University of Medical Sciences

Www.zahrasharifpoor6@gmail.com+98 44 4623 1364

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026